Cargando…
Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up
Pituitary apoplexy is a clinical syndrome caused by hemorrhage or infarction of a pituitary adenoma. There have been a few reports in the literature of rapid onset of pituitary apoplexy after goserelin injection. To the best of our knowledge, there is no publication in the literature reporting re-in...
Autores principales: | Aljabri, Belal, Lilleby, Wolfgang, Switlyk, Marta D., Tafjord, Gunnar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044649/ https://www.ncbi.nlm.nih.gov/pubmed/33868933 http://dx.doi.org/10.1016/j.eucr.2021.101648 |
Ejemplares similares
-
Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
por: Lilleby, Wolfgang, et al.
Publicado: (2015) -
Pituitary apoplexy
por: Ranabir, Salam, et al.
Publicado: (2011) -
Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin
por: Abdel Azim, Hamdy, et al.
Publicado: (2018) -
Management of pituitary apoplexy
por: Gupta, Bikram Kumar, et al.
Publicado: (2016) -
Gestational Pituitary Apoplexy
por: Annamalai, Anand K., et al.
Publicado: (2017)